Skip to main content

SIDMAP Introduces Metabolomic Profiling Technology, Services

NEW YORK, Sept. 2 (GenomeWeb News) - SIDMAP, a Los Angeles-based startup, on Wednesday introduced a metabolic profiling technology service based on a proprietary tracer-molecule technology and mass spectrometry.

 

The company, named after its Stable Isotope-based Dynamic Metabolic Profiling technology, is commercializing the approach as a service targeting drug discovery and development. The SIDMAP technology uses labeled metabolic substrate molecules (tracers) to track disease-characteristic metabolic pathways.

 

The technology was developed at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center by Laszlo Boros, an associate professor of pediatrics at the University of California, Los Angeles, and Paul Lee, UCLA professor of pediatrics, the company said in a statement.

 

SIDMAP has licensed the technology from LA Biomed. Financial details of the agreement were not disclosed, the company said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.